Lufwanyama Neonatal Survival Project (LUNESP)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
We seek to determine whether we can reduce day 28 mortality in Zambian newborns by training traditional birth attendants a modified version of the neonatal resuscitation protocol (NRP) and by improving their abiltiy to identify sepsis and initiate antibiotics in the field.
| Condition | Intervention |
|---|---|
|
Mortality |
Other: Neonatal resuscitation protocol Other: Standard of care |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Lufwanyama Neonatal Survival Project |
- mortality [ Time Frame: day 28 ]
- perinatal mortality [ Time Frame: day zero ]
- sepsis mortality [ Time Frame: deaths between days 1-28 ]
- cost effectiveness [ Time Frame: days 0-28 ]
- successful delivery of nevirapine prophylaxis to HIV exposed deliveries [ Time Frame: day zero umbilical cord dried blood spot ]
| Enrollment: | 3559 |
| Study Start Date: | September 2006 |
| Study Completion Date: | July 2009 |
| Primary Completion Date: | September 2008 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: intervention
TBAs who receive training and supplies for the intervention
|
Other: Neonatal resuscitation protocol
training in neonatal resuscitation and sepsis identification early treatment
|
|
Active Comparator: control
TBAs continuing with current standard of practice
|
Other: Standard of care
continued with current standard of care for birth attendants
|
Detailed Description:
This is a cluster randomized trial of the impact of providing additional training and supplies to traditional birth attendants in a rural setting in Zambia. 120 TBAs are randomized into intervention/control. Intervention TBAs receive NRP training, supplies for neonatal resuscitation, receiving blankets for thermoregulation, and amoxicillin tablets. Control TBAs continue according to prior standard of care. Primary outcome is mortality at 28 days life as a proportion of births attended by TBAs in each study arm.
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- TBA trained in safe delivery;
- willing to sign informed consent; willing to be randomized; willing to adhere to study procedures
Exclusion Criteria:
- TBA living outside of Lufwanyama district
Contacts and Locations
More Information
No publications provided by Boston University
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Davidson H. Hamer, Boston University School of Public Health |
| ClinicalTrials.gov Identifier: | NCT00518856 History of Changes |
| Other Study ID Numbers: | GHS-A-00-03-00020-00-4 |
| Study First Received: | August 20, 2007 |
| Last Updated: | March 29, 2011 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Boston University:
|
birth asphyxia neonatal sepsis maternal to child transmission of HIV |
ClinicalTrials.gov processed this record on May 21, 2013